Ampio Pharma Cash Flow - Annual (NYSEMKT:AMPE)

Add to My Stocks
$0.52 $0.02 (4%) AMPE stock closing price Sep 20, 2018 (Closing)

The financial analysis of AMPE requires an investor to check the cash flows for Ampio Pharma. Financials statements like the Ampio Pharma income statement and Ampio Pharma balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Ampio Pharma saw a cash impact of $16.14M from the issuance of AMPE shares. The cash flow statement helps in the Ampio Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Ampio Pharma has a positive cash and cash equivalents change of $3.31M.

View details of Ampio Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-51.89M-19.16M-33.71M-39.04M-24.52M-11.59M-18.35M-8.05M-0.02M-0.03M
Depreciation Depletion Amortization Cash-Flow1.53M1.35M1.54M-------
Net Increase (Decrease) in Assets Liabilities1.71M-0.53M-0.55M-0.25M1.2M-----0.01M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net37.23M3.71M6.27M7.91M4.05M1.41M9.12M4.42M--
Net Cash from (used by) Operating Activities
-11.4M-14.62M-26.44M-30.74M-19.13M-9.71M-9.13M-2.62M-0.02M-0.03M
Increase (Decrease) in Prop Plant And Equipment-0.07M-0.01M-0.23M-8.66M-1.31M--0.08M---
Acquisition Disposition of Subsidiaires---0.54M-------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities---1M--0.35M--0.03M---
Net Cash from (used by) Investment Activities
-0.07M-0.01M-1.77M-8.65M-1.66M--0.11M---
Issuance (Purchase) of Equity Shares16.14M3.9M-0.01M68.4M30.39M17.54M22.43M1.36M--
Issuance (Repayment) of Debt Securities--5.17M-------
Increase (Decrease) in Bank & Other Borrowings-------2.01M--
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-1.35M-0.37M-0.29M-4.99M-0.96M-1.52M-2.77M-0.15M--
Net Cash from (used by) Financing Activities
14.79M3.52M4.85M63.4M29.42M16.02M19.94M3.22M--
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
3.31M-11.1M-23.36M24.01M8.62M6.32M10.69M---
Cash & Equivalents at Beginning of Year4.89M15.99M50.32M26.3M17.68M11.36M----
Cash & Equivalents at Year End8.2M4.89M26.95M50.32M26.3M17.68M11.36M---
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Horizon Pharma financial analysis

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Ampio Pharma stock price history and Ampio Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Ampio Pharma had a Net Change in Cash and Cash Equivalents of $3.31M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Ampio Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Ampio Pharma reported a negative operating cash flow of $-11.4M for 2017 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.07M for AMPE in last 2017 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $14.79M for Ampio Pharma.

Key Financial Ratios For Ampio Pharma Cash Flow

FCF margin
0